Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Rheumatology|November 5, 2013
Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in JapanTakao Koike, Masayoshi Harigai, Shigeko Inokuma, et al.
Modern Rheumatology|January 26, 2011
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritisTakao Koike, Masayoshi Harigai, Shigeko Inokuma, et al.
Rheumatology International|February 19, 2011
Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance studyTakao Koike, Masayoshi Harigai, Shigeko Inokuma, et al.
Rheumatology International|February 18, 2011
Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritisTakao Koike, Masayoshi Harigai, Shigeko Inokuma, et al.
The Journal of Rheumatology|April 1, 2009
Postmarketing surveillance of the safety and effectiveness of etanercept in JapanTakao Koike, Masayoshi Harigai, Shigeko Inokuma, et al.
Rheumatology and Therapy|October 18, 2016
Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study)Takao Koike, Masayoshi Harigai, Naoki Ishiguro, et al.
Modern Rheumatology|December 5, 2015
Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritisMasayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, et al.
Modern Rheumatology|September 16, 2018
Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillanceMasayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, et al.
The Journal of Rheumatology|May 4, 2005
Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseasesShunichi Kumagai, Seiji Kawano, Tatsuya Atsumi, et al.
International Heart Journal|July 18, 2009
Effects of long-acting beraprost sodium (TRK-100STP) in Japanese patients with pulmonary arterial hypertensionTakeyoshi Kunieda, Norifumi Nakanishi, Hiromi Matsubara, et al.
Pageof 6